Long story short, you can block opioid receptor activation with something called an opioid antagonist.

简而言之，我们可以通过服用一种名叫“阿片拮抗剂”的药物来阻止阿片受体激活。

Treatment includes teprotumumab which blocks IGF-1R activation, it's approved by the FDA for the treatment of thyroid eye disease.

治疗手段包括Teprotumumab，可阻断IGF-1R的激活，在美国已被FDA批准用于甲状腺眼病的治疗。